Articles published by Better Therapeutics, Inc.
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
March 14, 2024
Via Business Wire
Tickers
BTTX
Via Business Wire
Tickers
BTTX
Frost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership Award
November 14, 2023
Via Business Wire
Tickers
BTTX
Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 09, 2023
Via Business Wire
Tickers
BTTX
Better Therapeutics to Participate in the American College of Lifestyle Medicine’s 2023 Annual Conference
October 26, 2023
Via Business Wire
Tickers
BTTX
Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
October 16, 2023
Via Business Wire
Tickers
BTTX
Better Therapeutics Announces Publication of LivVita Liver Disease Study Results in Gastro Hep Advances
October 05, 2023
Via Business Wire
Tickers
BTTX
Better Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 09, 2023
Via Business Wire
Tickers
BTTX
Better Therapeutics Announces $6.5MM Private Placement
April 06, 2023
Via Business Wire
Tickers
BTTX
Better Therapeutics to Participate in Two Upcoming Investor Conferences
February 09, 2023
Via Business Wire
Tickers
BTTX
Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results
December 08, 2022
Via Business Wire
Tickers
BTTX
Better Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 02, 2022
Via Business Wire
Tickers
BTTX
Better Therapeutics to Participate in BTIG Digital Health Forum
November 15, 2022
Via Business Wire
Tickers
BTTX
Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 14, 2022
Via Business Wire
Tickers
BTTX
Via Business Wire
Tickers
BTTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.